Skip to main content

Advertisement

Table 3 Percentages of Juvenile Arthritis Damage Index (JADI) articular and extraarticular items by therapeutic era in patients with oligoarthritis and polyarthritis

From: Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic era

  Oligoarthritis (n = 238) Polyarthritis(n = 270)
  MTX era (n = 102) Biologic era (n = 136) MTX era (n = 137) Biologic era (n = 133)
Articular
 Temporomandibular 7 (6.9) 10 (7.4) 16 (11.7) 13 (9.8)
 Cervical spine 2 (2.0) 1 (0.7) 13 (9.5) 2 (1.5)
 Shoulder 1 (1.0) 0 (0.0) 14 (10.2) 1 (0.8)
 Elbow 3 (2.9) 1 (0.7) 27 (19.7) 1 (0.8)
 Wrist 2 (2.0) 0 (0.0) 31 (22.6) 2 (1.5)
 Metacarpophalangeal 1 (1.0) 1 (0.7) 15 (10.9) 3 (2.3)
 Proximal interphalangeal 2 (2.0) 0 (0.0) 29 (21.2) 5 (3.8)
 Hip 1 (1.0) 2 (1.5) 17 (12.4) 1 (0.8)
 Knee 3 (2.9) 1 (0.7) 19 (13.9) 4 (3.0)
 Ankle 5 (4.9) 2 (1.5) 13 (9.5) 8 (6.0)
 Metatarsophalangeal 0 (0.0) 0 (0.0) 20 (14.6) 2 (1.5)
Extraarticular
 Ocular 13 (12.7) 1 (0.7) 8 (5.8) 6 (4.5)
 Muscular atrophy 6 (5.9) 6 (4.4) 13 (9.5) 2 (1.5)
 Osteoporosis 1 (1.0) 0 (0.0) 2 (1.5) 1 (0.8)
 Avascular necrosis 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.8)
 Scoliosis 6 (5.9) 4 (2.9) 11 (8.0) 1 (0.8)
 Leg length inequality 9 (8.8) 15 (11.0) 9 (6.6) 6 (4.5)
 Striae rubrae 0 (0.0) 0 (0.0) 3 (2.2) 1 (0.8)
 Subcutaneous atrophy 4 (3.9) 1 (0.7) 5 (3.6) 5 (3.8)
 Growth failure 2 (2.0) 0 (0.0) 17 (12.4) 1 (0.8)
 Pubertal delay 0 (0.0) 0 (0.0) 5 (3.6) 0 (0.0)
 Diabetes 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
 Amyloidosis 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
 Others 1 (1.0) 0 (0.0) 0 (0.0) 0 (0.0)
  1. Data are number positive/number with information available (percentage) unless otherwise indicated; reference [11]